These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27351565)

  • 1. Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease.
    Zhang H; Xu MG; Xie LJ; Huang M; Shen J; Xiao TT
    World J Pediatr; 2016 Aug; 12(3):308-313. PubMed ID: 27351565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are patients recovering from Kawasaki disease at increased risk for accelerated atherosclerosis? A meta-analysis.
    Zeng YY; Chen F; Zhang Y; Ji X
    World J Pediatr; 2021 Oct; 17(5):476-483. PubMed ID: 34553328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of peroxisome proliferator-activated receptor gamma and adiponectin predisposes Kawasaki disease patients to developing atherosclerosis.
    Fukunaga H; Kishiro M; Akimoto K; Ohtsuka Y; Nagata S; Shimizu T
    Pediatr Int; 2010 Oct; 52(5):795-800. PubMed ID: 20487372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?
    McCrindle BW; McIntyre S; Kim C; Lin T; Adeli K
    J Pediatr; 2007 Sep; 151(3):244-8, 248.e1. PubMed ID: 17719931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in children within 5 years after onset of Kawasaki disease.
    Ishikawa T; Iwashima S
    J Pediatr; 2013 Oct; 163(4):1117-21. PubMed ID: 23759425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities.
    Parihar M; Singh S; Vignesh P; Gupta A; Rohit M
    Pediatr Cardiol; 2017 Aug; 38(6):1123-1132. PubMed ID: 28512721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease: A brief history.
    Burns JC; Kushner HI; Bastian JF; Shike H; Shimizu C; Matsubara T; Turner CL
    Pediatrics; 2000 Aug; 106(2):E27. PubMed ID: 10920183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease.
    Ikemoto Y; Ogino H; Teraguchi M; Kobayashi Y
    Pediatr Cardiol; 2005; 26(6):782-6. PubMed ID: 16132279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse Wave Velocity in Kawasaki Disease.
    Iwazu Y; Minami T; Kotani K
    Angiology; 2017 Mar; 68(3):189-195. PubMed ID: 27225700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki Disease: Pathology, Risks, and Management.
    Seki M; Minami T
    Vasc Health Risk Manag; 2022; 18():407-416. PubMed ID: 35711626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kawasaki disease in children and adolescents: clinical data of Kawasaki patients in a western region (Tyrol) of Austria from 2003-2012.
    Binder E; Griesmaier E; Giner T; Sailer-Höck M; Brunner J
    Pediatr Rheumatol Online J; 2014 Sep; 12(1):37. PubMed ID: 27643389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis.
    Cheung YF; Yung TC; Tam SC; Ho MH; Chau AK
    J Am Coll Cardiol; 2004 Jan; 43(1):120-4. PubMed ID: 14715193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of subcutaneous fat during follow-up of a cohort of North Indian children with Kawasaki disease: a preliminary study.
    Suthar R; Singh S; Bhalla AK; Attri SV
    Int J Rheum Dis; 2014 Mar; 17(3):304-12. PubMed ID: 24517191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease.
    Chen X; Zhao ZW; Li L; Chen XJ; Xu H; Lou JT; Li LJ; Du LZ; Xie CH
    Lipids Health Dis; 2015 Dec; 14():166. PubMed ID: 26714775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid profile and fat patterning in children at a mean of 8.8 years after Kawasaki disease: a study from Northern India.
    Narsaria P; Singh S; Gupta A; Khullar M; Bhalla A
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-171-5. PubMed ID: 25236754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki disease before kawasaki at Tokyo university hospital.
    Shibuya N; Shibuya K; Kato H; Yanagisawa M
    Pediatrics; 2002 Aug; 110(2 Pt 1):e17. PubMed ID: 12165616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease.
    Ishikawa T; Seki K
    BMC Cardiovasc Disord; 2018 Feb; 18(1):30. PubMed ID: 29426283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction in adult patients with a history of Kawasaki disease.
    Niboshi A; Hamaoka K; Sakata K; Yamaguchi N
    Eur J Pediatr; 2008 Feb; 167(2):189-96. PubMed ID: 17345094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular health in Kawasaki disease.
    Selamet Tierney ES; Gal D; Gauvreau K; Baker AL; Trevey S; O'Neill SR; Jaff MR; de Ferranti S; Fulton DR; Colan SD; Newburger JW
    J Am Coll Cardiol; 2013 Sep; 62(12):1114-1121. PubMed ID: 23835006
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.